Seoul, South Korea

Jin-Ah Jeong

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jin-Ah Jeong: Innovator in Pharmaceutical Chemistry

Introduction

Jin-Ah Jeong is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various diseases. With a total of 5 patents to her name, her work has garnered attention in both academic and industrial circles.

Latest Patents

One of her latest patents is titled "Isoxazole derivatives as nuclear receptor agonists and uses thereof." This invention provides methods for treating or ameliorating metabolic diseases, cholestatic liver diseases, or organ fibrosis. It involves administering a therapeutically effective amount of a pharmaceutical composition that includes an isoxazole derivative or its acceptable salts. Another notable patent is "Phthalazinone derivatives and manufacturing process thereof." This invention relates to phthalazinone derivatives and includes pharmaceutical compositions aimed at inhibiting the activity of the Poly(ADP-riboside) polymerase enzyme.

Career Highlights

Throughout her career, Jin-Ah Jeong has worked with notable companies such as Ildong Pharm Co., Ltd. and Il Dong Pharmaceutical Co., Ltd. Her expertise in pharmaceutical development has led to advancements in drug formulations and therapeutic applications.

Collaborations

Jin-Ah has collaborated with esteemed colleagues, including Jae-Hoon Kang and Hong-Sub Lee. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Jin-Ah Jeong's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a key figure in the industry. Her work continues to impact the development of new treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…